Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 91, pseudogene (RN7SL91P) is a processed pseudogene belonging to a large family of 7SL RNA pseudogenes found dispersed in the human genome[4][3][5]. Unlike the canonical 7SL RNA, which is an integral component of the signal recognition particle (SRP) complex involved in targeting nascent secretory proteins to the endoplasmic reticulum membrane[1], RN7SL91P does not produce a functional RNA or protein. Most 7SL pseudogenes are considered noncoding remnants resulting from reverse transcription and integration of 7SL RNA-like sequences into the genome. There is no evidence that RN7SL91P is a protein-coding gene, nor is it known to function as a regulatory RNA at this time. It is not recognized as a therapeutic target, receptor, enzyme, or transporter. Therefore, while pseudogenes in general may have potential to act as regulatory RNAs in some contexts[2], RN7SL91P specifically has no established biological, pathological, or pharmacological relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 91, pseudogene (RN7SL91P).